- Home
- APLT
as 01-17-2025 4:00pm EST
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 128.0M | IPO Year: | 2019 |
| Target Price: | $6.10 | AVG Volume (30 days): | 7.5M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.43 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.60 - $10.62 | Next Earning Date: | 03-05-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | -94.55% | Revenue Growth (next year): | 2622.90% |
Latest Applied Therapeutics Inc. News
APLT Breaking Stock News: Dive into APLT Ticker-Specific Updates for Smart Investing
Insider Monkey
11 days ago
Is Applied Therapeutics (APLT) the Best Penny Stock to Invest In According to Media?
Insider Monkey
13 days ago
Here’s Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10
MT Newswires
a month ago
William Blair Downgrades Applied Therapeutics to Market Perform From Outperform
Benzinga
a month ago
Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data
MT Newswires
a month ago
Applied Therapeutics Names John Johnson as Executive Chair, Les Funtleyder as Interim CEO
MT Newswires
a month ago
RBC Cuts Price Target on Applied Therapeutics to $1.50 From $4, Keeps Sector Perform, Speculative Risk
GlobeNewswire
a month ago
Applied Therapeutics Appoints John H. Johnson as Executive Chairman
Simply Wall St.
2 months ago
Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?
Compare APLT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "APLT Applied Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.